MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 136 filers reported holding MERSANA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,136,000 | -16.0% | 157,259 | 0.0% | 0.53% | +2.9% |
| Q1 2021 | $2,544,000 | -48.3% | 157,259 | -15.0% | 0.52% | -48.8% |
| Q4 2020 | $4,922,000 | -9.4% | 184,959 | -36.6% | 1.01% | -6.3% |
| Q3 2020 | $5,433,000 | -37.6% | 291,781 | -21.5% | 1.08% | -57.6% |
| Q2 2020 | $8,700,000 | +797.8% | 371,781 | +123.6% | 2.54% | +681.2% |
| Q1 2020 | $969,000 | +1.7% | 166,250 | 0.0% | 0.32% | +43.2% |
| Q4 2019 | $953,000 | – | 166,250 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |